Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Acquired by Smartleaf Asset Management LLC

Smartleaf Asset Management LLC lifted its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) by 389.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,020 shares of the company’s stock after buying an additional 7,972 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Takeda Pharmaceutical were worth $132,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. FMR LLC grew its position in shares of Takeda Pharmaceutical by 10.9% during the third quarter. FMR LLC now owns 2,908,918 shares of the company’s stock worth $41,365,000 after buying an additional 286,052 shares in the last quarter. Van ECK Associates Corp raised its stake in shares of Takeda Pharmaceutical by 1.6% during the fourth quarter. Van ECK Associates Corp now owns 2,210,428 shares of the company’s stock worth $29,266,000 after purchasing an additional 35,192 shares during the last quarter. Managed Asset Portfolios LLC raised its stake in shares of Takeda Pharmaceutical by 0.3% during the third quarter. Managed Asset Portfolios LLC now owns 1,617,541 shares of the company’s stock worth $23,001,000 after purchasing an additional 4,069 shares during the last quarter. Stifel Financial Corp grew its holdings in Takeda Pharmaceutical by 103.9% during the third quarter. Stifel Financial Corp now owns 440,666 shares of the company’s stock worth $6,266,000 after acquiring an additional 224,594 shares during the period. Finally, Pathstone Holdings LLC grew its holdings in Takeda Pharmaceutical by 1.0% during the third quarter. Pathstone Holdings LLC now owns 430,676 shares of the company’s stock worth $6,124,000 after acquiring an additional 4,280 shares during the period. 9.17% of the stock is owned by institutional investors and hedge funds.

Takeda Pharmaceutical Trading Up 1.2 %

Shares of TAK stock opened at $15.18 on Friday. The business’s fifty day moving average price is $13.59 and its 200 day moving average price is $13.91. Takeda Pharmaceutical Company Limited has a 1-year low of $12.57 and a 1-year high of $15.22. The firm has a market capitalization of $48.29 billion, a PE ratio of 37.94, a P/E/G ratio of 0.24 and a beta of 0.46. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.31 and a quick ratio of 0.72.

Takeda Pharmaceutical (NYSE:TAK) last announced its quarterly earnings data on Thursday, January 30th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.08. Takeda Pharmaceutical had a return on equity of 9.39% and a net margin of 4.53%. As a group, sell-side analysts forecast that Takeda Pharmaceutical Company Limited will post 1.64 EPS for the current fiscal year.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.